SCHEMBL8522099

SCHEMBL8522099

O=C(OCC1CC(COC(=O)Oc2ccccc2)N1Cc1ccccc1)Oc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 4/20 0.43
CYP3A4 P08684 4/20 0.43
ALDH1A1 P00352 4/20 0.43
USP2 O75604 2/20 0.43
MAPK1 P28482 1/20 0.43
CHRM2 P08172 1/20 0.42
CHRM4 P08173 1/20 0.42
CHRM5 P08912 1/20 0.42
OPRK1 P41145 5/20 0.40
KCNH2 Q12809 5/20 0.40
OPRM1 P35372 3/20 0.40
OPRD1 P41143 1/20 0.40
TSHR P16473 3/20 0.39
CYP2C19 P33261 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
HSD11B1 P28845 1/20 0.39
NR1H2 P55055 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
MEN1 O00255 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8522094 1.00 CYP2D6 (0.43) CYP2D6CYP3A4ALDH1A1USP2MAPK1
SCHEMBL8522102 1.00 CYP2D6 (0.43) CYP2D6CYP3A4ALDH1A1USP2MAPK1
SCHEMBL8848434 0.79 CHRNB2 (0.40) CYP2D6ALDH1A1USP2CHRM2CHRM4
SCHEMBL8848447 0.79 CHRNB2 (0.40) CYP2D6ALDH1A1USP2CHRM2CHRM4
SCHEMBL8848438 0.79 CHRNB2 (0.40) CYP2D6ALDH1A1USP2CHRM2CHRM4
SCHEMBL8522579 0.78 CHRNB2 (0.42) ALDH1A1USP2TSHRHTTCHRNB2
SCHEMBL7241335 0.77 SIGMAR1 (0.55) CYP2D6CYP3A4ALDH1A1USP2MAPK1
SCHEMBL8309536 0.73 SMN1; SMN2 (0.38) ALDH1A1SMN1; SMN2HTTL3MBTL1
SCHEMBL8308796 0.73 SMN1; SMN2 (0.38) ALDH1A1SMN1; SMN2HTTL3MBTL1
SCHEMBL8308800 0.73 SMN1; SMN2 (0.38) ALDH1A1SMN1; SMN2HTTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0607374-B1 NOVEL CYCLIC LIPID DERIVATIVES AS POTENT PAF ANTAGONISTS PO HANG IRON & STEEL (KR) 1999-04-07 EP disclosed
US-5610310-A Cyclic lipid derivatives as potent PAF antagonists POHANG IRON & STEEL CO., LTD (KR) 1997-03-11 US disclosed
EP-0607374-A1 NOVEL CYCLIC LIPID DERIVATIVES AS POTENT PAF ANTAGONISTS POHANG IRON & STEEL CO., LTD. (KR) 1994-07-27 EP disclosed
WO-1994000447-A1 NOVEL CYCLIC LIPID DERIVATIVES AS POTENT PAF ANTAGONISTS POHANG IRON & STEEL CO., LTD. (KR) 1994-01-06 WO disclosed